| Her-2 NEGATIVE = 162 | Her-2 POSITIVE = 37 |
Recalled | 59 (36.4%) | 11 (29.7%) |
Further ipsilateral malignancy | 22 (13.5%) | 6 (16.2%) (OR 0.83, 95% CI 0.3 - 2.2) |
Contralateral malignancy | 2 (1.2%) | 0 |
B3/B4 | 5 (3.08%) | 1 (2.7%) |
MRI/PATH SIZE CONCORDANCE (WITHIN 10 MM) | 114 (70.3%) (p value > 0.1) | 18 (48.6%) (p value > 0.2) |
MRI/PATH SIZE DISCORDANCE (>10 MM DISCORDANCE) | 48 (29.6%) | 19 (51.3%) |
MRI > PATH SIZE (10 MM OR MORE DIFFERENCE) | 34/48 (70.8% OF DISCORDANCE) | 17/19 (89.4% OF DISCORDANCE) |